Add to ORKGThe cause of Idiopathic intracranial hypertension (IIH) remains unknown and no consensus exists on how patients should be managed. Acetazolamide is commonly used, but has never been examined in a randomised controlled trial. Reduction in body weight has been reported to improve the course of IIH in overweight individuals
There has been no clinical trial to evaluate the efficacy of acetazolamide treatment for idiopathic ...
Idiopathic intracranial hypertension (IIH) is characterized by elevation of intracranial pressure (I...
Idiopathic intracranial hypertension (IIH) is an uncommon disorder characterized by increased intrac...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
Treatment of idiopathic intracranial hypertension (IIH) is based on anecdotal uncontrolled data as t...
Idiopathic intracranial hypertension (IIH) is a condition which affects predominantly overweight wom...
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affect...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH} also called pseudotumor cerebri, is a disorder of elevate...
Idiopathic intracranial hypertension (IIH) is a rare but important disease associated with significa...
The purpose of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) was to determine whe...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
Limited data exists to guide treatment of idiopathic intracranial hypertension (IIH). We examined th...
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure (ICP) ...
There has been no clinical trial to evaluate the efficacy of acetazolamide treatment for idiopathic ...
Idiopathic intracranial hypertension (IIH) is characterized by elevation of intracranial pressure (I...
Idiopathic intracranial hypertension (IIH) is an uncommon disorder characterized by increased intrac...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
Treatment of idiopathic intracranial hypertension (IIH) is based on anecdotal uncontrolled data as t...
Idiopathic intracranial hypertension (IIH) is a condition which affects predominantly overweight wom...
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affect...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH} also called pseudotumor cerebri, is a disorder of elevate...
Idiopathic intracranial hypertension (IIH) is a rare but important disease associated with significa...
The purpose of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) was to determine whe...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
Limited data exists to guide treatment of idiopathic intracranial hypertension (IIH). We examined th...
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure (ICP) ...
There has been no clinical trial to evaluate the efficacy of acetazolamide treatment for idiopathic ...
Idiopathic intracranial hypertension (IIH) is characterized by elevation of intracranial pressure (I...
Idiopathic intracranial hypertension (IIH) is an uncommon disorder characterized by increased intrac...